Cargando…
SOCS4 expressed by recombinant HSV protects against cytokine storm in a mouse model
Oncolytic viruses are genetically engineered viruses designed for the treatment of solid tumors, and are often coupled with the antitumor immunity of the host. The challenge of using oncolytic herpes simplex virus (oHSV) as an efficacious oncolytic agent is the potential host tissue damage caused by...
Autores principales: | Ren, Shuqi, Chen, Xiaoqing, Huang, Rongquan, Zhou, Grace Guoying, Yuan, Zhuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365695/ https://www.ncbi.nlm.nih.gov/pubmed/30569160 http://dx.doi.org/10.3892/or.2018.6935 |
Ejemplares similares
-
Suppressor of Cytokine Signaling 4 (SOCS4) Protects against Severe Cytokine Storm and Enhances Viral Clearance during Influenza Infection
por: Kedzierski, Lukasz, et al.
Publicado: (2014) -
Essential role of M1 macrophages in blocking cytokine storm and pathology associated with murine HSV-1 infection
por: Jaggi, Ujjaldeep, et al.
Publicado: (2021) -
Suppressor of cytokine signaling (SOCS)-3 gene transfer protects against collagen-induced arthritis
por: van de Loo, FAJ, et al.
Publicado: (2004) -
Worldwide circulation of HSV-2 × HSV-1 recombinant strains
por: Koelle, David M., et al.
Publicado: (2017) -
Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
por: Brans, Richard, et al.
Publicado: (2010)